BC Week In Review | Aug 31, 2018
Clinical News

FDA approves Ortho Dermatologics' tretinoin lotion for acne

The Ortho Dermatologics unit of Bausch Health Companies Inc. (TSX:BHC; NYSE:BHC) said FDA approved Altreno tretinoin 0.05% topical lotion to treat acne vulgaris in patients ages nine and older. Ortho Dermatologics said the product is...
BioCentury | Jun 30, 2018

Eyes on launches

The annual summer slowdown isn’t restricted to just the stock market this year, as the clinical catalyst calendar also appears to be on holiday in 3Q18. Buysiders are therefore turning their attention to a spate...
BC Week In Review | Jan 19, 2018
Clinical News

FDA accepts Valeant's tretinoin lotion NDA for acne

Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) said FDA accepted for a review an NDA for Altreno tretinoin 0.05% (IDP-121) to treat acne. The PDUFA date is Aug. 27. Altreno is a topical tretinoin in a...
Items per page:
1 - 3 of 3